Persistent hyperinsulinaemic hypoglycaemia

Seminars in Neonatology

Volumn 7, Issue 1, 2002, Pages 95-100

  De Lonlay, Pascale ^a   Touati, Guy ^a   Robert, Jean Jacques ^a   Saudubray, Jean Marie ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Diazoxide; Diffuse CI; Focal CI; Glucagon; GLUD1 gene; Hyperammonaemia; Hyperinsulinism; KIR6.2 gene; PHHI; Somatostatine; SUR1 gene

Indexed keywords

ARTICLE; BRAIN INJURY; DIAGNOSTIC TEST; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INBORN ERROR OF METABOLISM; INFANT; INSULIN RELEASE; MACROSOMIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN PERIOD; NEWBORN SCREENING; PANCREAS RESECTION; PROGNOSIS;

EID: 0036306878     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1053/siny.2001.0090     Document Type: Article

References (34)

1. Clinical aspects and course of neonatal hyperinsulinism
2. Hyperinsulinism in infants and children
3. Practical management of hyperinsulinism in infancy
4. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: A retrospective review of 77 cases and analysis of efficacy-predicting criteria
5. A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene
6. Hyperinsulinemic hypoglycemia as presenting symptom of Carbohydrate-Deficiency Glycoproteins
7. Facial dysmorphism in persistent hyperinsulinemic hypoglycemia
8. Hyperinsulinemia and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene
9. Calcium-stimulated insulin secretion in diffuse and focal forms of congenital hyperinsulinism
10. Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations
11. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism
12. Is 95% pancreatectomy the procedure of choice for treatment of persistent hyperinsulinemic hypoglycemia of the neonate?
13. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyper-insulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy
14. Maternal allele loss with somatic reduction to homozygosity of the paternally-inherited mutation of the SUR1 gene leads to congenital hyperinsulinism in focal islet cell adenomatous hyperplasia of the pancreas
15. Neonatal hyperinsulinemic hypoglycemia: Heterogeneity of the syndrome and keys for differential diagnosis
16. Diffuse and focal nesidioblastosis. A clinocopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia
17. The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: Deficiency of pancreatic D cells or hyperactivity of B cells?
18. Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: The pathologist's role
19. Hyperinsulinism in children: Diagnostic value of pancreatic venous sampling correlated with clinical, pathological and surgical outcome in 25 cases
20. B-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy
21. Neurological outcome of hyperinsulinism: A series of 100 patients
22. Familial and sporadic hyperinsulinism: Histopathological findings and segregation analysis support a single autosomal recessive disorder
23. Molecular study of 31 focal forms of persistent hyperinsulinemic hypoglycemia of infancy (CI): Association of a reduction to homozygosity of a SUR1/KIR6.2 mutation and unbalanced expression of 11p15 imprinted genes
24. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy
25. Mutations in the sulfonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews
26. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy
27. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1
28. Familial hyperinsulinism caused by an activating glucokinase mutation
29. An autosomal dominant form of familial persistent hyperinsulinemic hypoglycemia of infancy, not linked to the sulfonylurea receptor
30. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma
31. Characterization of mutations in patients with multiple endocrine neoplasia type 1
32. Menin, the product of the MEN1 gene, is a nuclear protein
33. Chromosome 11 allele loss in sporadic insulinoma
34. The association between tuberous sclerosis and insulinoma